-Hindustan Times India’s generic drug manufacturers have flooded the market with cheaper medicines to treat hepatitis C after Gilead Sciences Inc’s patent application was rejected in January 2015. Thanks to domestic drugmakers, the world is looking to India to reduce the price of hepatitis C drug further. “By scaling up the production of generic medicines, India is playing a pivotal role globally in reducing the prices of medicines for hepatitis C,” said Henk...
More »SEARCH RESULT
Total Matching Records found : 6301
Physician, heal thyself: How graft afflicted NRHM in UP -Devesh K Pandey
-The Hindu Chief medical officers of 72 districts colluded with politicians and contractors in swindling funds meant for poor patients; the CBI has filed 82 cases so far Investigations into the Rs. 9,000-crore National Rural Health Mission (NRHM) scam in Uttar Pradesh have led to the arrest of 149 persons, with the Central Bureau of Investigation arraigning 350 people as accused in 82 cases of corruption, cheating, forgery and conspiracy registered so...
More »Dark clouds over the PDS -Jean Dreze
-The Hindu The imposition of Aadhaar-based biometric authentication in the Public Distribution System threatens to disrupt recent progress with PDS reforms. It also deprives millions of people of essential food entitlements. India’s Public Distribution System (PDS) has improved steadily during the last 10 years. The system used to be most ineffective and corruption-ridden, with leakages of around 50 per cent at the national level, going up to 80 or 90 per cent...
More »Retaining MGNREGA's core -Brinda Karat
-The Hindu Held to account by the Supreme Court, the Central government is using opaque methods to change the key provisions of the employment guarantee scheme and make it targeted instead of universal. There is a pithy saying in Hindi that the elephant has two sets of teeth, one for show and the other to eat. This seems an apt description of the approach of the Narendra Modi government towards the implementation...
More »Average cost of type-1 diabetes management: 27k/year -Shailvee Sharda
-The Times of India LUCKNOW: Seeing their child in tears each time an insulin pen pricks the belly isn't the only pain parents of a type-1 diabetic child have to go through. The cost associated with management of the disease hurts equally, if not more. A middle-income family spends an estimated 18% of family income on the disease. The findings are from a study conducted by the department of endocrinology at Sanjay...
More »
